Intellia Therapeutics, Inc. · NASDAQ:NTLA
Vanguard Portfolio Management LLC reported a 5.30% stake in Intellia Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 29, 2026
Vanguard Portfolio Management LLC reported a 5.30% stake in Intellia Therapeutics, Inc., 6,266,007 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 6,266,007
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Portfolio Management | 5.30% | 6,266,007 |
Source
Related
- Intellia Therapeutics, Inc.
- Vanguard Portfolio Management LLC
- Intellia Therapeutics, Inc. shareholders
- Form 4 · Dube Michael P · Oct 6, 2026
- Form 4 · Leonard John M · Aug 24, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Dulac Edward J III · Jul 24, 2026
- Form 4 · Dulac Edward J III · Jul 6, 2026